Practice Information

New

• Theft or Loss of Narcotic or Controlled Drug Report

Archived Information

A

ADVERSE DRUG REACTION

• Federal Government Factsheet

ADVERTISING

• Drugs - Overview, Health Canada, November 2000

• Drugs - Direct-to-Consumer, Centres of Excellence for Women's Health, Spring 2003

AIDS/HIV

• AIDS Declaration (1997) Joint declaration between FIP and the World Health Organization on the role of the pharmacist in the fight against AIDS.

ALTERNATIVE HEALTH PRODUCTS

• Pharmacists' Responsibility in Providing Advice About or Selling Alternative Health Products

B

BENZODIAZEPINES:

• Operational Procedures for Pharmacists complying with the requirements of the Benzodiazepines and Other Targeted Substances Regulations in Community & Institutional Practices
• Guidance Document for Pharmacists - Health Canada 08/00
• Guidance Document for Hospitals - Health Canada 08/00
• Frequently Asked Questions - Health Canada 11/00

C

CENTRAL FILL PRESCRIPTION PROCESSING

• Proposal for the Implementation of Central Fill and Central Processing in Canada - November 2002

CLOZAPINE

• Health Canada letter to provincial licensing bodies (June 30, 2004)

CODE OF ETHICS

• Code of Ethics (2004) FIP believes that all pharmacists, irrespective of nationality, culture or beliefs should conform to this Code in order to ensure that the patient's interests are protected.

CODEINE

• Pharmacists' role in the sale of Schedule II codeine preparations (December 2002) Council policy of the Nova Scotia College of Pharmacists

COUNTERFEIT DRUGS

• Counterfeit Medicines (1999) Outlines the position of FIP with respect to counterfeit medicines, and indicates the obligations of national pharmacy organizations and individual pharmacists in fighting against them.

D

DOCUMENTATION

DRUGS, FEDERAL APPROVAL OF

• How Drugs are Reviewed in Canada, Health Canada Fact Sheet, March 2003
• Notice of Compliance with conditions, Health Canada Fact Sheet, March 2002

DRUGS, DISPOSAL OF

• "Recycling" and Disposal of Dispensed Drugs

DRUGS, DONATIONS OF

• Good Practice in Donation of Medicines (1997) Gives guidance to pharmacists who are involved in, or who are asked to give advice on, the collection of medicines which are to be sent as donations following natural or other disasters.
  

DRUG INFORMATION

• Drug Information Resources

DRUG NAMES

• Look-Alike, Sound-Alike Drug Product Names Health Canada fact sheet, November 2003

E

ELECTRONIC TRANSMISSION OF PRESCRIPTIONS

• Recommendations for Implementation of Electronic Prescription in Canada, May 2003
• NAPRA's Presentation on Proposed Electronic-Prescription Security Standards, May, 2001
• Proposal for Electronic Prescription Security Standards, May 2001
• Report on the Transfer of Authority to Fill Prescriptions by Electronic Transmission, March 1998
• Study for the National Association of Pharmacy Regulatory Authorities: Secure System for Transmitting Prescriptions and Related Patient Information Between Prescribers and Pharmacists

EMERGENCY CONTRACEPTION

• Saskatchewan Pharmacists Prescribing Emergency Contraception, Minister's Announcement, September 2003
• Oral Contraceptives for Emergency Contraception Purposes (NAPRA statement)
• Pharmacy Practice Resources

EPHEDRINE, EPHEDRA, PSEUDOEPHEDRINE

• Health Canada Notice to Manufacturers, Distributors and Retailers re: Ephedrine, Ephedra, Pseudoephedrine - October 28, 2003

ERRORS, DISPENSING/DRUG

• Medication Errors Association with Prescribed Medication (1999) Aims to define the term "medication error" and suggest a standard nomenclature to categorize medication errors and their severity. Also makes recommendations to members of the health care delivery system designed to improve safety in the manufacturing, ordering, labelling, dispensing, administration and use of medicines.
• Medication Errors (Practice Resources)

EXPORT OF PRESCRIPTIONS

• NAPRA Testimony before the US Health and Human Services Task Force on Drug Importation - April 27, 2004
• Letter to Honorable Pierre Pettigrew, calling for ban - April 21, 2004
• Letter from Diane Gorman, Assistant Deputy Minister, Health Canada re: Internet Pharmacy - October 28, 2003
• Commercial Importation and Exportation of Drugs in Dosage Form under the Food and Drugs Act , July 2003
• Prescribing for US Patients - A Summary  January 2003 
• NAPRA/NABP Communique on the Cross-Border Sale of Prescriptions - May 2003
• NAPRA Forum on the Export of Prescription Drugs to the U.S. Proceedings - February 2003
• Canada adopts VIPPS for Online Pharmacies - December 2002
• NABP announces Canadian VIPPS Program - November 2002

F

FAX TRANSMISSION, PRESCRIPTIONS

• Fax Transmission of Prescriptions

I

INTERNET

• Letter from Diane Gorman, Health Canada - October 28, 2003
• It's Your Health: Buying Drugs over the Internet fact sheet - July 2003
• NAPRA's Internet Pharmacy Standards - November 2001

M

MANUFACTURING/COMPOUNDING

• Good Manufacturing Practices (GMP) - January 2004
• "Manufacturing and Compounding Drug Products in Canada" - Policy Framework from Health Canada, July 2000
• Ensuring Quality & Safety of Medicinal Products (2000) Joint statement between FIP and the International Federation of Pharmaceutical Manufacturers Associations to provide guidance to ensure good quality and proven safety and efficacy of medicinal products.

MARIJUANA

• Federal government's interim policy on providing marijuana for medical use - July 2003
• Federal government fact sheet on medical use - May 2003
• Health Canada's "Information for the Patient" - October 2003
• Health Canada's "Information for Health Care Professionals" - October 2003
• Health Canada's "Product Information - Dried Marihuana" - July 2003

MELATONIN

• Melatonin Regulated as a Natural Health Product - October 2005

METHADONE MAINTENANCE TREATMENT

• Best Practices Guidelines, Health Canada, 2002
• Literature Review, Health Canada, 2002

MODAFANIL

• Schedule Status (February 2004)

N

NEFAZADONE PRODUCTS

NON-PRESCRIPTION DRUGS

• Responsible Self-Medication (1999) Joint statement between FIP and the World Self-Medication Industry to provide guidance to pharmacists, patients and the industry regarding the safe and effective use of non-prescription medicines.
• Self-Care Guidelines (1996) Describes FIP's policy on the responsibilities of pharmacists when advising on self-medication. Areas covered include "pharmacy premises", "sales promotion", "advice on the treatment of symptoms", "request for medicine by name", "referral notes" and "confidentiality".

P

PATIENT, INFORMATION

• .Mandatory Patient Package Inserts

PHARMACEUTICAL CARE

• Pharmaceutical Care (1998) Gives guidance to pharmacists and national health care organizations as they begin to implement broad pharmaceutical services in their countries. FIP supports the concept of pharmaceutical care but recognizes the individual needs of different countries.
  

PHARMACIST

• Pharmacists' Endorsement of Health Products - NAPRA Model Policy (November 2003)
• Prescribing (NAPRA Submission to the Alberta Health Professions Advisory Board) (October 30th 2003)

• Pharmacists' Responsibility when asked to Provide a Drug that may Harm the Patient

PHARMACY PRACTICE

• Pharmacy Practice Guidelines (1996) International guidelines aimed at raising the quality of pharmaceutical care provided by pharmacists around the world.

PHARMACY TECHNICIANS

• Techwise: Hiring Smart, College of Pharmacists of British Columbia (May 2003)

PRECURSORS

• The New Precursor Regulations (May 6, 2003)

PRESCRIPTIONS, TO OTHER JURISDICTIONS

• "Taking Medicine Across Borders"

PRIVACY

• Privacy Legislation Guidelines for Pharmacists

R

"REFUSAL TO FILL"

• Pharmacists' Refusal to Provide Products or Services for Moral or Religious Reasons

S

SAMPLING

• "Model Regulatory Guidelines for the Distribution of Medication Samples by Pharmacists"

SPECIAL ACCESS PROGRAMME FOR DRUGS

• Fact Sheet (Nov 22, 2002)
• Instructions For Making a Special Access Request 2003-2004
• Request Form 2003-2004
• Instructions for Making a Future Use Special Access Request 2003-2004
• Future Use Records Form 2003-2004

SUBSTITUTION/PRODUCT SELECTION

• Product Selection (1997) Gives guidance to pharmacists on the use of generic substitution. FIP supports generic substitution under certain well-defined conditions, but does not support therapeutic substitution except in emergencies.

SYRINGES

• Travel Advisory, acp news. May/June 2003

V

Validation Guidelines for Pharmaceutical Dosage Forms, Health Canada, August 2004